{"result": {"id": "c8f60f05-b0df-40d8-a185-05d4407451a6", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "**Summary of CKD and SGLT2I:**  \n\nSGLT2 inhibitors (SGLT2i) are recommended for patients with chronic kidney disease (CKD) to reduce kidney disease progression and provide cardiorenal protection, irrespective of diabetes status. These benefits are supported for CKD patients with an estimated glomerular filtration rate (eGFR) of ≥20 mL/(min·1.73m²). The use of SGLT2i in this population is advised to mitigate disease progression and improve both renal and cardiovascular outcomes.", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751559768, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 109, "prompt_tokens": 197, "total_tokens": 306, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 64}, "prompt_cache_hit_tokens": 64, "prompt_cache_miss_tokens": 133}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: [\"CKD\", \"SGLT2I\"]\nDescription List: [\"SGLT2i is recommended for patients with CKD to reduce kidney disease progression\", \"SGLT2i provide cardiorenal protection in CKD patients regardless of diabetes status\", \"SGLT2is are recommended for CKD patients with eGFR ≥20mL/(min·1.73m2).\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_159075dc7f5b3b83f4900bbb02ed64a022e571b105d7ecde8bd120284dcfe203_v2"}